nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—Sulfathiazole—CYP19A1—autistic disorder	0.0118	0.867	CrCbGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—GRM5—autistic disorder	0.0105	0.0107	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Other—ADRB2—autistic disorder	0.0105	0.0106	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR1D—autistic disorder	0.0103	0.0104	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—OXTR—autistic disorder	0.0102	0.0103	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—OXTR—autistic disorder	0.0101	0.0102	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AVPR1A—autistic disorder	0.00976	0.00989	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—PRKCB—autistic disorder	0.00964	0.00977	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—autistic disorder	0.00942	0.00955	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—OXTR—autistic disorder	0.00913	0.00925	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—OPRM1—autistic disorder	0.00898	0.0091	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR5A—autistic disorder	0.00887	0.00899	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1D—autistic disorder	0.00883	0.00895	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—AVPR1A—autistic disorder	0.00843	0.00855	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—MAPK1—autistic disorder	0.00833	0.00845	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Other—HTR2A—autistic disorder	0.00819	0.00831	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—OXT—autistic disorder	0.00808	0.00819	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—OXT—autistic disorder	0.00797	0.00808	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—OXTR—autistic disorder	0.00789	0.008	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GABBR2—autistic disorder	0.00754	0.00765	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—AVPR1A—autistic disorder	0.00723	0.00732	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—autistic disorder	0.00722	0.00732	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—OPRM1—autistic disorder	0.00703	0.00713	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—OXTR—autistic disorder	0.00676	0.00685	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR1D—autistic disorder	0.00672	0.00681	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GRM8—autistic disorder	0.00625	0.00634	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR1B—autistic disorder	0.00624	0.00633	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—WNT2—autistic disorder	0.00605	0.00614	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—OPRM1—autistic disorder	0.00602	0.00611	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—DRD1—autistic disorder	0.0058	0.00588	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—DRD3—autistic disorder	0.00562	0.0057	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—AVP—autistic disorder	0.00554	0.00561	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—AVPR1A—autistic disorder	0.0055	0.00558	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—AVP—autistic disorder	0.00547	0.00554	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR1B—autistic disorder	0.00535	0.00542	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—OXT—autistic disorder	0.00535	0.00542	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GRM5—autistic disorder	0.00531	0.00539	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—OXTR—autistic disorder	0.00515	0.00522	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—SCT—autistic disorder	0.00509	0.00516	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR5A—autistic disorder	0.00501	0.00508	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD1—autistic disorder	0.00497	0.00504	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—MAPK1—autistic disorder	0.00497	0.00504	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—autistic disorder	0.00495	0.00502	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GABBR1—autistic disorder	0.00486	0.00493	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—ADM—autistic disorder	0.00486	0.00493	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—DRD3—autistic disorder	0.00482	0.00488	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—HTR2A—autistic disorder	0.00461	0.00467	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—OPRM1—autistic disorder	0.00459	0.00465	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—ADRB2—autistic disorder	0.00455	0.00462	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR5A—autistic disorder	0.00455	0.00461	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—autistic disorder	0.00437	0.00443	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GABBR2—autistic disorder	0.00426	0.00432	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—autistic disorder	0.00412	0.00418	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR1B—autistic disorder	0.00407	0.00413	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—OXT—autistic disorder	0.00407	0.00413	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—HRAS—autistic disorder	0.00399	0.00404	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—ADRB2—autistic disorder	0.0039	0.00396	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GABBR2—autistic disorder	0.00387	0.00392	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR1D—autistic disorder	0.0038	0.00385	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—DRD1—autistic disorder	0.00379	0.00384	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM5—autistic disorder	0.00376	0.00381	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM5—autistic disorder	0.00371	0.00376	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—DRD3—autistic disorder	0.00367	0.00372	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—AVP—autistic disorder	0.00367	0.00372	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—POMC—autistic disorder	0.00363	0.00368	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—autistic disorder	0.00356	0.00361	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CALCA—autistic disorder	0.00355	0.00359	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GRM8—autistic disorder	0.00353	0.00358	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR1D—autistic disorder	0.00345	0.0035	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PDE4A—autistic disorder	0.00332	0.00337	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—autistic disorder	0.00327	0.00331	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—autistic disorder	0.00323	0.00327	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PLA2G4A—autistic disorder	0.00322	0.00326	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRM8—autistic disorder	0.00321	0.00325	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AVPR1A—autistic disorder	0.00311	0.00315	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—WNT2—autistic disorder	0.00311	0.00315	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—GPX1—autistic disorder	0.00308	0.00312	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	0.00305	0.00309	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PDE4A—autistic disorder	0.00302	0.00306	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GRM5—autistic disorder	0.003	0.00304	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—VIP—autistic disorder	0.003	0.00304	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—ADRB2—autistic disorder	0.00297	0.00301	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—OXTR—autistic disorder	0.00291	0.00295	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—SCT—autistic disorder	0.00288	0.00292	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AVPR1A—autistic disorder	0.00282	0.00286	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NRP2—autistic disorder	0.0028	0.00284	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—AVP—autistic disorder	0.00279	0.00283	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADM—autistic disorder	0.00275	0.00278	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GABBR1—autistic disorder	0.00275	0.00278	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—VIP—autistic disorder	0.00273	0.00276	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRM5—autistic disorder	0.00273	0.00276	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR5A—autistic disorder	0.00269	0.00273	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PDE4B—autistic disorder	0.00268	0.00271	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—autistic disorder	0.00265	0.00269	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—OXTR—autistic disorder	0.00264	0.00268	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—SCT—autistic disorder	0.00261	0.00265	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—OPRM1—autistic disorder	0.00259	0.00263	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GABBR1—autistic disorder	0.00249	0.00253	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADM—autistic disorder	0.00249	0.00253	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	0.00245	0.00248	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	0.00244	0.00247	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PDE4B—autistic disorder	0.00243	0.00246	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—OPRM1—autistic disorder	0.00235	0.00239	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—MAOB—autistic disorder	0.00232	0.00236	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR2A—autistic disorder	0.00232	0.00235	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR1B—autistic disorder	0.0023	0.00233	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—OXT—autistic disorder	0.0023	0.00233	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GABBR2—autistic disorder	0.00229	0.00232	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—DRD1—autistic disorder	0.00214	0.00217	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR1B—autistic disorder	0.00209	0.00212	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—OXT—autistic disorder	0.00209	0.00212	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—DRD3—autistic disorder	0.00207	0.0021	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR1D—autistic disorder	0.00204	0.00207	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL5—autistic disorder	0.00203	0.00206	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CALCA—autistic disorder	0.002	0.00203	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	0.00196	0.00199	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRLR—autistic disorder	0.00196	0.00199	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—DRD1—autistic disorder	0.00194	0.00197	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM8—autistic disorder	0.00189	0.00192	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—DRD3—autistic disorder	0.00188	0.00191	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	0.00186	0.00189	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—POMC—autistic disorder	0.00186	0.00188	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL5—autistic disorder	0.00184	0.00187	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—WNT2—autistic disorder	0.00183	0.00186	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CALCA—autistic disorder	0.00182	0.00184	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—autistic disorder	0.00181	0.00184	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GHR—autistic disorder	0.00181	0.00183	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS2—autistic disorder	0.0018	0.133	CrCbGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	0.00179	0.00182	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDE4A—autistic disorder	0.00178	0.00181	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADRB2—autistic disorder	0.00168	0.0017	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AVPR1A—autistic disorder	0.00167	0.00169	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VIP—autistic disorder	0.00161	0.00163	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRM5—autistic disorder	0.00161	0.00163	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—autistic disorder	0.00159	0.00161	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AVP—autistic disorder	0.00158	0.0016	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—OXTR—autistic disorder	0.00156	0.00158	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SCT—autistic disorder	0.00154	0.00157	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADRB2—autistic disorder	0.00152	0.00155	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.00149	0.00151	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GABBR1—autistic disorder	0.00147	0.00149	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADM—autistic disorder	0.00147	0.00149	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EIF4E—autistic disorder	0.00145	0.00147	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDE4B—autistic disorder	0.00144	0.00146	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AVP—autistic disorder	0.00143	0.00145	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.00143	0.00145	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP19A1—autistic disorder	0.00141	0.00143	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—OPRM1—autistic disorder	0.00139	0.00141	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP19A1—autistic disorder	0.00139	0.00141	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PLA2G4A—autistic disorder	0.00135	0.00137	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR2A—autistic disorder	0.00131	0.00133	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—COMT—autistic disorder	0.00131	0.00133	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTP1—autistic disorder	0.0013	0.00132	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—MAOA—autistic disorder	0.0013	0.00132	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—COMT—autistic disorder	0.00129	0.00131	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTP1—autistic disorder	0.00128	0.0013	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GZMB—autistic disorder	0.00127	0.00129	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—OXT—autistic disorder	0.00123	0.00125	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR1B—autistic disorder	0.00123	0.00125	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM1—autistic disorder	0.0012	0.00121	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR2A—autistic disorder	0.00119	0.00121	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM1—autistic disorder	0.00118	0.0012	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PRKCB—autistic disorder	0.00115	0.00117	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DRD1—autistic disorder	0.00115	0.00116	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TSC1—autistic disorder	0.00115	0.00116	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	0.00113	0.00115	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ACADSB—autistic disorder	0.00112	0.00114	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—INPP1—autistic disorder	0.00112	0.00114	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NTRK2—autistic disorder	0.00112	0.00113	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DRD3—autistic disorder	0.00111	0.00113	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CG—autistic disorder	0.0011	0.00112	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL5—autistic disorder	0.00109	0.0011	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CALCA—autistic disorder	0.00107	0.00109	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—POMC—autistic disorder	0.00105	0.00106	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PRKCB—autistic disorder	0.00105	0.00106	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CG—autistic disorder	0.001	0.00101	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—BTD—autistic disorder	0.000998	0.00101	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—RORA—autistic disorder	0.000952	0.000965	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—POMC—autistic disorder	0.000952	0.000965	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRL—autistic disorder	0.000949	0.000963	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADRB2—autistic disorder	0.000901	0.000913	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TDO2—autistic disorder	0.000849	0.00086	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AVP—autistic disorder	0.000846	0.000858	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—POMC—autistic disorder	0.000846	0.000858	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF2—autistic disorder	0.000843	0.000854	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DHCR7—autistic disorder	0.000798	0.000809	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLA2G4A—autistic disorder	0.000796	0.000807	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2—autistic disorder	0.000775	0.000786	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MEF2C—autistic disorder	0.000774	0.000785	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—EXT1—autistic disorder	0.000756	0.000767	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC6A8—autistic disorder	0.000756	0.000767	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ITGB3—autistic disorder	0.000754	0.000765	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DAO—autistic disorder	0.000722	0.000732	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR2A—autistic disorder	0.000704	0.000714	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2—autistic disorder	0.000704	0.000713	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UPB1—autistic disorder	0.000692	0.000701	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TSC2—autistic disorder	0.000669	0.000678	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LEP—autistic disorder	0.000655	0.000664	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APOE—autistic disorder	0.000655	0.000664	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM5—autistic disorder	0.000643	0.000652	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ASMT—autistic disorder	0.000643	0.000652	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCB—autistic disorder	0.000617	0.000626	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC25A12—autistic disorder	0.000605	0.000613	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APC—autistic disorder	0.000591	0.000599	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CG—autistic disorder	0.000591	0.000599	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC19A1—autistic disorder	0.000588	0.000596	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGF—autistic disorder	0.000584	0.000592	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—POMC—autistic disorder	0.000562	0.00057	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1—autistic disorder	0.000541	0.000548	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	0.000541	0.000548	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAPK1—autistic disorder	0.000538	0.000546	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADSL—autistic disorder	0.000524	0.000532	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—XDH—autistic disorder	0.000514	0.000521	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SERPINE1—autistic disorder	0.000514	0.000521	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—STX1A—autistic disorder	0.000505	0.000512	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NPAS2—autistic disorder	0.000505	0.000512	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TCN2—autistic disorder	0.000487	0.000494	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADA—autistic disorder	0.000465	0.000471	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	0.00046	0.000466	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	0.00044	0.000446	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HRAS—autistic disorder	0.000432	0.000438	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—RORA—autistic disorder	0.000424	0.00043	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2—autistic disorder	0.000416	0.000421	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—autistic disorder	0.000414	0.000419	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MAOB—autistic disorder	0.000397	0.000403	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTEN—autistic disorder	0.000391	0.000397	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	0.000378	0.000383	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TPH2—autistic disorder	0.000369	0.000375	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DPYD—autistic disorder	0.000363	0.000368	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	0.000341	0.000346	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CACNA1C—autistic disorder	0.000338	0.000343	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	0.000325	0.000329	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK1—autistic disorder	0.000318	0.000322	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DHFR—autistic disorder	0.000307	0.000312	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	0.000259	0.000263	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HRAS—autistic disorder	0.000255	0.000259	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—autistic disorder	0.000244	0.000248	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP19A1—autistic disorder	0.000241	0.000244	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	0.000226	0.000229	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—COMT—autistic disorder	0.000224	0.000227	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTP1—autistic disorder	0.000223	0.000226	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MAOA—autistic disorder	0.000222	0.000225	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAT—autistic disorder	0.000217	0.00022	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM1—autistic disorder	0.000205	0.000208	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLA2G4A—autistic disorder	0.000205	0.000208	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPX1—autistic disorder	0.000196	0.000199	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTHFR—autistic disorder	0.000181	0.000183	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOE—autistic disorder	0.000168	0.000171	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CG—autistic disorder	0.000152	0.000154	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—POMC—autistic disorder	0.000145	0.000147	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—autistic disorder	0.000115	0.000117	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTEN—autistic disorder	0.000101	0.000102	CbGpPWpGaD
